Article Versions Notes

Shah NJ, Della Pia A, Wu T, Williams A, Weber M, Sinclaire B, Gourna Paleoudis E, Alaoui A, Lev-Ari S, Adams S, et al. Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials. Cancers. 2024; 16(12):2223. https://doi.org/10.3390/cancers16122223

Shah, Neil J., Alexandra Della Pia, Tianmin Wu, Aquino Williams, Melinda Weber, Brittany Sinclaire, Elli Gourna Paleoudis, Adil Alaoui, Shaked Lev-Ari, Shari Adams, and et al. 2024. "Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials" Cancers 16, no. 12: 2223. https://doi.org/10.3390/cancers16122223

Shah, N. J., Della Pia, A., Wu, T., Williams, A., Weber, M., Sinclaire, B., Gourna Paleoudis, E., Alaoui, A., Lev-Ari, S., Adams, S., Kaufman, J., Parikh, S. B., Tonti, E., Muller, E., Serzan, M., Cheruku, D., Lee, A., Sridhar, A., Hee, B. P., ... Atkins, M. B. (2024). Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials. Cancers, 16(12), 2223. https://doi.org/10.3390/cancers16122223